pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4532 |
Genomic Coordinates | chr20: 57895394 - 57895444 |
Description | Homo sapiens miR-4532 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-4532 |
Sequence | 6| CCCCGGGGAGCCCGGCG |22 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SNRPD3 | ||||||||||||||||||||
Synonyms | SMD3, Sm-D3 | ||||||||||||||||||||
Description | small nuclear ribonucleoprotein D3 polypeptide | ||||||||||||||||||||
Transcript | NM_004175 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SNRPD3 | |||||||||||||||||||||
3'UTR of SNRPD3 (miRNA target sites are highlighted) |
>SNRPD3|NM_004175|3'UTR 1 TTTTCTAAGTTGAACAGAACTTTGTCCTTTTTTCTTTCAGGTTATCTGAGTTCATTGGAGTGGGTGCTTGTGCATATATG 81 CTAGGTATCTTTTGCCATCTTTCTCTTTAGATCAGGGGAAATGTTTAAGCTAAATAAATCTGGGGGGTTTTTTGTTCTGT 161 TTTGTTTTGTTTTCTTTGAGAAAATAAGGACTTTGTGTTCATTTGAAGTTTGCTTTGGCTAAATTTTGACACCCTGGGGG 241 ATGTCCTGGGAGAATGCCAGTACTTTGAAATAGCACAGCTATTGATGAGATTTTAAGCTGCTGTTCCTGGCCAGTTGCAG 321 GTTAAGCCCCAGAAAAGTTCACCTTGGAGAAGCTCCGAGAACACACAGATTGTGTCTCATTCATCTTCAGACACAGGCAC 401 ATAGTGTGGCACTTTGTTCAGTTAACATTTGTGGAGCTGTCATCAGCTCAGCTTTAACAACACAGGTGACTCTTTCCCTT 481 GATAAAGTCATAGGTAATTCAGGGGCTGGGTGCGGCGGCTCACGCATGTAATCCCAGCACTTTGGGAGGCCAAGGCGGGC 561 GGATCACGAGGTCAGGAGTTCGAGACCAGCCTGGCCAATATGGTGAAACCTCGTGTGTACTAAAAATAAAAAAATTAGCC 641 GGGTGCGGTGGCATGTACCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGAAGATTCGCTTGAACCCAGGAGGTGGACA 721 TTGCAGTGAGCAGAGATCATGCCACTGTACTCCAGCTTGGGTGACAGAGCGAGACTGCACCTCAAAAAAAAAAAAGTAAT 801 TCAGGGGATCCTAGTGGCCAGCTTCCTTGGCTCGTATACTGGCTACAACAAGTAGTTTTGTGGTGATTTGTGGAAACAGA 881 TTCTTGGGAGCATATCAGAGCATCTCAGCATTGATTGGCACATCCATAGTTGTTAATGTAGGAAGGGTGACCAGCAGCTC 961 AGCACAGTGGCTTGCTTCCAGCACTCTGGGAGGCTGAGGTAGAGGATTGTTTGAGAGGAGTTCAAAACCAGCCCGCGAGA 1041 CATAGTGAGACCCTGTCTCTACAAAAAATTCTAAAAATTAACTTGGCATGGTGGTGCACACCTGTAGTCCTCGCTACTAG 1121 GGAGGCTGAGGTGGGAGGATCACTTGAGCCTGGGAGTATGAGGCTGCAGTGAGCTATGACCTTGCCACTGTACTCCAGCC 1201 TGGGCAAAAGAGCAAGACTTTGTCTTTAAAGAAAAATAAGTAGTAGTAAAGAGTATAAGATACACAGGGTGAATAATTGT 1281 GACAAAAACACAGAAACTGGAAAAGCAGCCTGAAAAAATCAAATCACCAAAAAGAGGTCTTGCCAGGTATTCATTATGGT 1361 ATGAGCTACAGCATAAGCCATCAAGAGGAAAACTGATCAATTATTGGCTTTTAGAATATTGCTCATTGAACAGATTATTC 1441 AAGTAATGAAAGAGGAGGGGAAAAAAATCCAGCACATTAGTTAACCTGGCATCAATTAATGAGGTTCTAATAAGCTTTGT 1521 CTTATGATACTACCTGGAGGTTACAGAGCTGGTATTCTGAGGAATAAGCATCAGTGAGTTGGTCAGATACAATAGACGTT 1601 TAAAATAGGGCTTCAGGCCAAACATGGTGCCCCACGCCTATAATGCCAGCACTTTGGGAGGTCGAGGCGGGAGGATCACT 1681 TGAACCTAGGAGTTTGAGACTAGCCTGGGCTGTTAAGCTTTGTTAACCAAGACCGCATCTCTACAAAAAATTGAAAAGTA 1761 GCTGGGCACAGCTGATGCCTGCAGTCCCAGCTATCCTGGAGGTTGAGGCAGGACGACCACATGAGCCCAGGAGATTAAGG 1841 CTGCAGTGAGCTATAATTGCACCACTGCACTCCAGCCTGGATGACAGTGAGACCCTGTCTCTTAAATAAAAAACAAATGA 1921 AAGCAGTGGTTTTCAACATCAACTAAGGATCTTATTAGAAATGAAGACTGCAAGCCGCACACCTGGAGTGGGGCCCAGGA 2001 ATCTGCATTTTAAACAATTCCCTGGTCCCCAGATAAGTAATTCTTAAGTATTCTATCTTAAGTAGACCTAAAGCCGTATT 2081 TTGACCCTGTACTAGTATGTTATTTTAGTATAATCATTACTGAATTCATCATACTTTTACAGTAAACAGTACTTACTTTG 2161 AATAATAACACATTACACTTAATAGTAGTGAACTGCATCCTCGATATCAAAAGCGACTTTTGATGTAGTTCACTCTGGAC 2241 CCGTACAGGAACACCAGCCTTGCAGATTCTCCACGCAATGGAAACTGGCTATAACCCTACCTAGATCTGAAAAGTGAAGG 2321 GGGATCAACCTAAAATATGTAGCTTTGTAAACAGTTTTATATCCTGCATCTTAGGGGGGAAAATCAGTTGACGCAGATTG 2401 AAAACAAGTTGTTCCATAAGGTTTATTATGAAAAACAGTAGCCCTCCTACCCTGCCTTTACCCCACTTTCCTTGCCTCAC 2481 AGTAGTCTGTCCAACTCTTGGCTGATTTGTTTGTATTTACCTCCATGTCTCAATATGAACATGTTTTCATGACTATTCCT 2561 TGATGGTTTTTTGTTTGCTTGTTTTAAGACGGTCTCACTCTTCCCCAGGCGGGAGTGCAATGGCACAATCATGGCTCACT 2641 GCAGCCTCAACCTTCTCGGGCTCAGGTGATTCTCCCACCTCAGCCTCCTGAGTAGCTAGAAATACTGGTGCACACCACCA 2721 TGCCTAGCTAATTTTTGTATTTTTTGTAGAGACAGGGTTTTGCCATGTTGCCCAAGCTGGTCTTGAACTCCGGGGCTCAA 2801 GTGATCTGCCCGCCTCGGCCTGCTGGGATTATAGGTGTGAGCCACTGCACCCGGCCACCATTATCTTTTGAATCCTCTCT 2881 TCCTCCTGCCCACCATGAATTTACTTCCTCTCACCCATCTCCCTGATATTGTAATTCTGGTTAGATCATATTCAGTGTCA 2961 AATTATTAAGATGTGATTAAACTTTTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 6634.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000215829.3 | 3UTR | CCCGGGAGGUGGAGCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
119 hsa-miR-4532 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT451366 | UQCR11 | ubiquinol-cytochrome c reductase, complex III subunit XI | 2 | 2 | ||||||||
MIRT451448 | ZNF556 | zinc finger protein 556 | 2 | 4 | ||||||||
MIRT458550 | CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | 2 | 2 | ||||||||
MIRT460274 | SLC26A2 | solute carrier family 26 member 2 | 2 | 2 | ||||||||
MIRT460365 | TXNDC16 | thioredoxin domain containing 16 | 2 | 4 | ||||||||
MIRT460539 | TM4SF5 | transmembrane 4 L six family member 5 | 2 | 2 | ||||||||
MIRT463626 | YY1 | YY1 transcription factor | 2 | 2 | ||||||||
MIRT468524 | SERTAD2 | SERTA domain containing 2 | 2 | 4 | ||||||||
MIRT469966 | PTPRF | protein tyrosine phosphatase, receptor type F | 2 | 8 | ||||||||
MIRT470076 | PTGES2 | prostaglandin E synthase 2 | 2 | 2 | ||||||||
MIRT474926 | KCTD20 | potassium channel tetramerization domain containing 20 | 2 | 2 | ||||||||
MIRT479976 | CARD10 | caspase recruitment domain family member 10 | 2 | 2 | ||||||||
MIRT485533 | GPRIN1 | G protein regulated inducer of neurite outgrowth 1 | 2 | 2 | ||||||||
MIRT485939 | ECSIT | ECSIT signalling integrator | 2 | 4 | ||||||||
MIRT486421 | RXRA | retinoid X receptor alpha | 2 | 2 | ||||||||
MIRT487665 | HPCAL1 | hippocalcin like 1 | 2 | 4 | ||||||||
MIRT488113 | POU3F1 | POU class 3 homeobox 1 | 2 | 4 | ||||||||
MIRT490648 | FEM1A | fem-1 homolog A | 2 | 2 | ||||||||
MIRT491313 | LRFN1 | leucine rich repeat and fibronectin type III domain containing 1 | 2 | 2 | ||||||||
MIRT491345 | CPNE5 | copine 5 | 2 | 2 | ||||||||
MIRT492688 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT496879 | AHCYL2 | adenosylhomocysteinase like 2 | 2 | 2 | ||||||||
MIRT499243 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT508211 | SLC35E1 | solute carrier family 35 member E1 | 2 | 2 | ||||||||
MIRT532712 | SNRPD3 | small nuclear ribonucleoprotein D3 polypeptide | 2 | 2 | ||||||||
MIRT540807 | SLC35F5 | solute carrier family 35 member F5 | 2 | 2 | ||||||||
MIRT563529 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 2 | ||||||||
MIRT607723 | LIMS1 | LIM zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT608089 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | 2 | 2 | ||||||||
MIRT618519 | SELPLG | selectin P ligand | 2 | 2 | ||||||||
MIRT624702 | AQR | aquarius intron-binding spliceosomal factor | 2 | 2 | ||||||||
MIRT624769 | AKR1D1 | aldo-keto reductase family 1 member D1 | 2 | 2 | ||||||||
MIRT629974 | MRPL36 | mitochondrial ribosomal protein L36 | 2 | 2 | ||||||||
MIRT631355 | ZFP82 | ZFP82 zinc finger protein | 2 | 2 | ||||||||
MIRT631425 | CDNF | cerebral dopamine neurotrophic factor | 2 | 2 | ||||||||
MIRT631664 | NDUFV3 | NADH:ubiquinone oxidoreductase subunit V3 | 2 | 2 | ||||||||
MIRT631734 | SF3B1 | splicing factor 3b subunit 1 | 2 | 2 | ||||||||
MIRT632333 | TCEANC2 | transcription elongation factor A N-terminal and central domain containing 2 | 2 | 2 | ||||||||
MIRT632418 | SLC30A5 | solute carrier family 30 member 5 | 2 | 2 | ||||||||
MIRT632530 | PSMB2 | proteasome subunit beta 2 | 2 | 2 | ||||||||
MIRT633263 | LDLR | low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT634326 | SLC43A2 | solute carrier family 43 member 2 | 2 | 2 | ||||||||
MIRT634752 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT635411 | KIAA1614 | KIAA1614 | 2 | 2 | ||||||||
MIRT636280 | RFFL | ring finger and FYVE like domain containing E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT636290 | RAD51L3-RFFL | RAD51L3-RFFL readthrough | 2 | 2 | ||||||||
MIRT641737 | TXNL1 | thioredoxin like 1 | 2 | 2 | ||||||||
MIRT643527 | ERAP2 | endoplasmic reticulum aminopeptidase 2 | 2 | 2 | ||||||||
MIRT643554 | C11orf70 | chromosome 11 open reading frame 70 | 2 | 2 | ||||||||
MIRT647026 | NQO2 | N-ribosyldihydronicotinamide:quinone reductase 2 | 2 | 2 | ||||||||
MIRT647297 | RBM43 | RNA binding motif protein 43 | 2 | 2 | ||||||||
MIRT648123 | SEMA3E | semaphorin 3E | 2 | 4 | ||||||||
MIRT648610 | TPCN2 | two pore segment channel 2 | 2 | 2 | ||||||||
MIRT648716 | IL10RB | interleukin 10 receptor subunit beta | 2 | 2 | ||||||||
MIRT649424 | CDC14B | cell division cycle 14B | 2 | 2 | ||||||||
MIRT650028 | DSG3 | desmoglein 3 | 2 | 2 | ||||||||
MIRT650280 | TAS2R5 | taste 2 receptor member 5 | 2 | 2 | ||||||||
MIRT654238 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT657031 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 2 | ||||||||
MIRT658406 | FAM212B | family with sequence similarity 212 member B | 2 | 2 | ||||||||
MIRT661079 | FFAR2 | free fatty acid receptor 2 | 2 | 2 | ||||||||
MIRT661528 | NWD1 | NACHT and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT661875 | PDLIM5 | PDZ and LIM domain 5 | 2 | 2 | ||||||||
MIRT662099 | ZNF419 | zinc finger protein 419 | 2 | 2 | ||||||||
MIRT663637 | HM13 | histocompatibility minor 13 | 2 | 2 | ||||||||
MIRT663702 | ABHD17B | abhydrolase domain containing 17B | 2 | 2 | ||||||||
MIRT663844 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT664768 | MESDC2 | mesoderm development LRP chaperone | 2 | 2 | ||||||||
MIRT665480 | VSTM4 | V-set and transmembrane domain containing 4 | 2 | 2 | ||||||||
MIRT666532 | RNF157 | ring finger protein 157 | 2 | 2 | ||||||||
MIRT668106 | GK5 | glycerol kinase 5 (putative) | 2 | 2 | ||||||||
MIRT669741 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | 2 | 2 | ||||||||
MIRT671009 | MOB4 | MOB family member 4, phocein | 2 | 2 | ||||||||
MIRT671582 | SPIRE2 | spire type actin nucleation factor 2 | 2 | 2 | ||||||||
MIRT673260 | INO80 | INO80 complex subunit | 2 | 2 | ||||||||
MIRT673532 | ADRBK2 | G protein-coupled receptor kinase 3 | 2 | 2 | ||||||||
MIRT674713 | FAM73A | mitoguardin 1 | 2 | 2 | ||||||||
MIRT675204 | ZNF554 | zinc finger protein 554 | 2 | 2 | ||||||||
MIRT676487 | DSN1 | DSN1 homolog, MIS12 kinetochore complex component | 2 | 2 | ||||||||
MIRT676704 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT676850 | ZMYM1 | zinc finger MYM-type containing 1 | 2 | 2 | ||||||||
MIRT676854 | RAB3B | RAB3B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT676914 | PHLDA3 | pleckstrin homology like domain family A member 3 | 2 | 2 | ||||||||
MIRT676999 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT677187 | PDE12 | phosphodiesterase 12 | 2 | 2 | ||||||||
MIRT677472 | SLC7A11 | solute carrier family 7 member 11 | 2 | 2 | ||||||||
MIRT677561 | C19orf52 | translocase of inner mitochondrial membrane 29 | 2 | 2 | ||||||||
MIRT677778 | FKTN | fukutin | 2 | 2 | ||||||||
MIRT677895 | DCP1A | decapping mRNA 1A | 2 | 2 | ||||||||
MIRT677995 | GATC | glutamyl-tRNA amidotransferase subunit C | 2 | 2 | ||||||||
MIRT678238 | HMGB1 | high mobility group box 1 | 2 | 4 | ||||||||
MIRT678312 | MCM8 | minichromosome maintenance 8 homologous recombination repair factor | 2 | 2 | ||||||||
MIRT678436 | PDE4C | phosphodiesterase 4C | 2 | 2 | ||||||||
MIRT678479 | RNF222 | ring finger protein 222 | 2 | 2 | ||||||||
MIRT678590 | ZNF91 | zinc finger protein 91 | 2 | 2 | ||||||||
MIRT678862 | SLC7A14 | solute carrier family 7 member 14 | 2 | 2 | ||||||||
MIRT679240 | LRP10 | LDL receptor related protein 10 | 2 | 2 | ||||||||
MIRT679387 | WDR92 | WD repeat domain 92 | 2 | 2 | ||||||||
MIRT679500 | ZNF106 | zinc finger protein 106 | 2 | 2 | ||||||||
MIRT679580 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2 | 2 | ||||||||
MIRT679826 | TMEM106B | transmembrane protein 106B | 2 | 2 | ||||||||
MIRT679859 | ZFP30 | ZFP30 zinc finger protein | 2 | 2 | ||||||||
MIRT680472 | C3 | complement C3 | 2 | 2 | ||||||||
MIRT683698 | LAX1 | lymphocyte transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT684267 | PRPF4 | pre-mRNA processing factor 4 | 2 | 2 | ||||||||
MIRT689404 | ZNF573 | zinc finger protein 573 | 2 | 2 | ||||||||
MIRT694756 | ZNF843 | zinc finger protein 843 | 2 | 2 | ||||||||
MIRT695955 | FANCM | Fanconi anemia complementation group M | 2 | 2 | ||||||||
MIRT696365 | EIF2S3 | eukaryotic translation initiation factor 2 subunit gamma | 2 | 2 | ||||||||
MIRT700681 | PPAP2B | phospholipid phosphatase 3 | 2 | 2 | ||||||||
MIRT701214 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT702195 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT706799 | RAI1 | retinoic acid induced 1 | 2 | 2 | ||||||||
MIRT711086 | NEUROD2 | neuronal differentiation 2 | 2 | 2 | ||||||||
MIRT715997 | RGS12 | regulator of G protein signaling 12 | 2 | 2 | ||||||||
MIRT716399 | SEPT5 | septin 5 | 2 | 2 | ||||||||
MIRT718442 | RAB11B | RAB11B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT722159 | ARHGAP40 | Rho GTPase activating protein 40 | 2 | 2 | ||||||||
MIRT724960 | PTK6 | protein tyrosine kinase 6 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|